Print page Print page
Switch language
Hvidovre Hospital - a part of Copenhagen University Hospital

An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit.

Research output: Contribution to journalJournal article

  1. Presence of SARS-CoV-2 in semen and the impact of COVID-19 on the male reproductive system

    Research output: Contribution to journalReviewpeer-review

  2. Danish Whole-Genome-Sequenced Candida albicans and Candida glabrata Samples Fit into Globally Prevalent Clades

    Research output: Contribution to journalJournal articlepeer-review

  3. A major outbreak of covid-19 at a residential care home

    Research output: Contribution to journalJournal articlepeer-review

  • Ulla Balslev
  • Annie Bremmelgaard
  • E Svejgaard
  • Jeannette Havstreym
  • Henrik Westh
View graph of relations
From February through July, 2000, there was an accumulation of mecA-negative borderline resistant Staphylococcus aureus (BORSA) in the Department of Dermatology. BORSA was isolated in 37 samples from 11 patients. The isolates were typed by antibiogram, phage type, pulsed-field gel electrophoresis (PFGE), and spa genotyping that confirmed that they were indistinguishable from one another. In May, 2000, an intervention was initiated focusing on infection control. In-patients with BORSA were discharged and antibiotic treatment was stopped, if possible. Emphasis was put on disinfection of shared utensils and individualization of previously shared creams and lotions. After the intervention, BORSA was isolated from another 3 patients before the outbreak was terminated. A case-control study was undertaken to identify possible risk factors for being a BORSA patient. Compared to the controls, the patients with BORSA had more severe skin disease, were more often hospitalized, and had more bed days.
Original languageEnglish
JournalMicrobial Drug Resistance
Issue number1
Pages (from-to)78-81
Number of pages4
Publication statusPublished - 2005

ID: 32502342